Date 2022/12/28 Location Online Presentation Download Download Chinese Version Download English Version Video Recording (English interpretation) Note N/ARead More
Published Date:2022-12-23 Original Link:https://www.onenessbio.com/en/news_detail193_1.htm No 1 Date of announcement 2022/12/23 Time of announcement 17:19:54 Subject Oneness Biotech to Present at the 41st Annual J.P. Morgan Healthcare Conference To which item it meets paragraph 12 Date of events 2023/01/11 Statement Date of institutional investor conference: 2023/01/11 Time of institutional investor conference: 08:00 (CST) Location of institutional...Read More
Published Date:2022-12-21 Original Link:https://www.onenessbio.com/en/news_detail192_1.htm No 1 Date of announcement 2022/12/21 Time of announcement 17:12:56 Subject Oneness and Microbio (Shanghai) signed an agreement with Cho Pharma to jointly develop glycosylation-based nucleic acid delivery technology. To which item it meets paragraph 12 Date of events 2022/12/28 Statement Date of institutional investor conference:2022/12/28 Time of institutional investor conference:15:00...Read More
Published Date:2022-12-20 Original Link:https://www.onenessbio.com/en/news_detail191_1.htm No 2 Date of announcement 2022/12/20 Time of announcement 17:16:40 Subject Oneness and Microbio (Shanghai) signed an agreement with Cho Pharma to jointly develop glycosylation-based nucleic acid delivery technology. To which item it meets paragraph 53 Date of events 2022/12/20 Statement Date of occurrence of the event:2022/12/20 Company name:ONENESS BIOTECH CO.,...Read More
Published Date:2022-12-20 Original Link:https://www.onenessbio.com/en/news_detail190_1.htm No 1 Date of announcement 2022/12/20 Time of announcement 17:00:32 Subject Oneness Biotech Co., Ltd. receives a Malaysian patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2022/12/20 Statement Date of occurrence of the event:2022/12/20 Company...Read More
Published Date:2022-12-06 Original Link:https://www.onenessbio.com/en/news_detail189_1.htm No 1 Date of announcement 2022/12/06 Time of announcement 17:07:51 Subject Oneness has been invited for a poster presentation with on-site Q&A for the Phase 3 MRCT post-hoc analysis of the DFU new drug, Fespixon at IDF Congress 2022. To which item it meets paragraph 12 Date of events 2022/12/07 Statement...Read More
Published Date:2022-12-02 Original Link:https://www.onenessbio.com/en/news_detail188_1.htm No 1 Date of announcement 2022/12/02 Time of announcement 20:03:27 Subject The post-market hard-to-heal cases treated by the DFU new drug, Fespixon have been accepted for an oral presentation at 2022 CDS To which item it meets paragraph 12 Date of events 2022/12/04 Statement Date of institutional investor conference:2022/12/04 Time of...Read More
Published Date:2022-11-29 Original Link:https://www.onenessbio.com/en/news_detail185_1.htm No 1 Date of announcement 2022/11/29 Time of announcement 15:27:42 Subject The trading of Oneness securities in centralized securities exchange market follows Announcement or Notice of Attention to Trading Information To which item it meets paragraph 53 Date of events 2022/11/29 Statement Date of occurrence of the event:2022/11/29 Cause of occurrence:Proceeded...Read More
